Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Jacek Osek
 -- 1542 2022-12-22 10:16:55 |
2 format
Jason Zhu
 Meta information modification 1542 2022-12-23 04:58:16 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Osek, J.;  Wieczorek, K. Listeria monocytogenes. Encyclopedia. Available online: https://encyclopedia.pub/entry/39075 (accessed on 19 May 2024).
Osek J,  Wieczorek K. Listeria monocytogenes. Encyclopedia. Available at: https://encyclopedia.pub/entry/39075. Accessed May 19, 2024.
Osek, Jacek, Kinga Wieczorek. "Listeria monocytogenes" Encyclopedia, https://encyclopedia.pub/entry/39075 (accessed May 19, 2024).
Osek, J., & Wieczorek, K. (2022, December 22). Listeria monocytogenes. In Encyclopedia. https://encyclopedia.pub/entry/39075
Osek, Jacek and Kinga Wieczorek. "Listeria monocytogenes." Encyclopedia. Web. 22 December, 2022.
Listeria monocytogenes
Edit
This entry is adapted from the peer-reviewed paper 10.3390/pathogens11121491

Listeriosis is a serious food-borne illness, especially in susceptible populations, including children, pregnant women, and elderlies. The disease can occur in two forms: non-invasive febrile gastroenteritis and severe invasive listeriosis with septicemia, meningoencephalitis, perinatal infections, and abortion. Expression of each symptom depends on various bacterial virulence factors, immunological status of the infected person, and the number of ingested bacteria. Internalins, mainly InlA and InlB, invasins (invasin A, LAP), and other surface adhesion proteins (InlP1, InlP4) are responsible for epithelial cell binding, whereas internalin C (InlC) and actin assembly-inducing protein (ActA) are involved in cell-to-cell bacterial spread. L. monocytogenes is able to disseminate through the blood and invade diverse host organs. In persons with impaired immunity, the elderly, and pregnant women, the pathogen can also cross the blood–brain and placental barriers, which results in the invasion of the central nervous system and fetus infection, respectively. 

: L. monocytogenes listeriosis virulence traits host infection

1. Introduction

Listeria monocytogenes was first identified by Murray, Webb, and Swann in 1924, as a gram-positive bacillus responsible for epidemic cases of mononucleosis, a disease affecting laboratory rabbits and guinea pigs, and named it Bacterium monocytogenes [1]. A few years later, similar bacteria were isolated from humans in Denmark by Nyfeldt, who described that this microorganism was the cause of infectious mononucleosis [2]. Then, L. monocytogenes was recognized as a cause of sporadic infections in workers contacted with diseased animals [3]. Currently, L. monocytogenes is considered as one of the most dangerous bacterial pathogens responsible for food-borne illnesses in humans [3][4].
At present, the genus Listeria consists of 26 species, including 18 Listeria species recognized and described for the first time in 2009 [5][6][7]. However, only two species, L. monocytogenes and L. ivanovii, are considered pathogenic for humans, but the infections of people with the latter one are very rare [8][9]. There is also little information on L. seeligeri isolation from human sporadic listeriosis cases [10]. Furthermore, L. innocua has been identified in a person with fatal listeriosis, which suggests that at least some strains of this Listeria species are pathogenic for humans and may be able to cause the disease [11].
L. monocytogenes has been often identified in domestic and wild animals, and especially ruminants are mostly affected, often without any clinical symptoms, but excreting the bacteria in their feces [12]. Bacteria occur ubiquitously in nature and have been detected in surface water, soil, plant, silage, sewage, and food production environments. They are able to grow at various temperatures ranging from −0.4 °C to 45 °C, pH between 4.6 and 9.5, and have the ability to persist in salt concentrations up to 20% [13][14]. These features allow L. monocytogenes to survive and multiply under extreme environmental conditions often present at food production facilities [15][16]. Thus, it is one of the most important food-borne pathogens responsible for sporadic infections or disease outbreaks, admittedly with rather low case numbers, but with a high mortality rate of 20–30% worldwide [17]. The food-connected way of L. monocytogenes infection in humans was unclear until the 1980s, when, during several outbreaks in the USA and Switzerland, various foods including dairy products, meat products, seafood products, and vegetables were indicated as the source of bacteria [18][19]. Infection via direct contact with animals or humans with listeriosis or with contaminated environments is also possible, although it is very rare [20][21][22].

2. Treatment of Listeriosis

L. monocytogenes is susceptible to many different antimicrobials that are used for gram-positive bacteria [23][24]. These include β-lactams, gentamicin, erythromycin, tetracycline, rifampicin, and vancomycin. On the other hand, L. monocytogenes is naturally resistant to cephalosporins, nalidixic acid, and polymyxin E [23]. Furthermore, most isolates are not susceptible to fluoroquinolones and cephalosporins of the third (e.g., cefotaxime) and fourth (cefepime) generations, nor to fosfomycin, oxacillin, and lincosamides [25]. High resistance to tetracyclines has been also reported in a few strains [23][26]. Antimicrobial resistance/susceptibility of L. monocytogenes strains varies widely and depends on sampling sites, time of sampling, source of isolates, and geographical origin.
In 1988, the first multiresistant (i.e., showing resistance to three or more classes of antimicrobials) L. monocytogenes strain of human origin was described in France [27]. It displayed resistance to chloramphenicol, erythromycin, streptomycin, and tetracycline. The genes responsible for resistance to these antibiotics were located on a 37 kb plasmid. Since then, several other L. monocytogenes strains with antimicrobial multiresistance patterns have been isolated from different clinical, food, and environmental origins [26][28][29][30][31].
Based on L. monocytogenes in vitro antimicrobial resistance results, treatment of severe listeriosis with β-lactams (penicillin or ampicillin) alone or combined with an aminoglycoside (e.g., kanamycin or gentamicin) is recommended [28][32]. Additionally, in cases of reduced sensitivity or resistance of the strains to β-lactams, other antimicrobial substances that are effective against gram-positive bacteria may be used, e.g., tetracyclines, erythromycin, chloramphenicol, vancomycin, and trimethoprim/sulfamethoxazole [32]. The latter antimicrobials are recommended for patients with an allergy to penicillin, whereas persons with bacteremia due to L. monocytogenes may be treated with vancomycin [32]. Furthermore, erythromycin can be used in patients with an allergy to ampicillin and/or gentamicin [33]. During pregnancy of L. monocytogenes-infected women, ampicillin or erythromycin intravenously or amoxicillin orally are used for at least 14 days, or even until delivery [34]. When the woman does not tolerate penicillin or amoxicillin, trimethoprim with sulfamethoxazole are the drugs of choice [34]. However, trimethoprim can damage the fetus in the early stages of pregnancy, including its heart and nervous system; therefore, patients with penicillin intolerance expecting a baby can be treated with erythromycin that is safe for fetus [35][36].
An increasing resistance of L. monocytogenes against antimicrobials, including antibiotics, led to the search for alternative therapies [37]. One of them is the application of bacteriocins, which are natural peptides produced by various bacteria [38][39]. Several bacteriocins are stable in gastrointestinal conditions, possess a low toxicity, and show a significant effect against pathogenic bacteria, including antibiotic-resistant strains [40][41]. It was shown that nisin (produced by Lactococcus lactis) and pediocin (secreted by Pediococcus acidilactici), demonstrated inhibitory activity against L. monocytogenes both in vitro and in vivo [42][43].
Another group of antibacterial substances that are promising alternatives to antibiotics are natural products of plant origin that possess different mechanisms of action directed towards increasing membrane permeability, decreasing its integrity, or disruption of bacterial efflux pumps [44]. Among them are terpenoids such as limonene and carvacrol, which has been shown to be effective against L. monocytogenes [45][46].
The efficacy of other phytochemicals such as trans-cinnamaldehyde, carvacrol, and thymol in reducing L. monocytogenes virulence was demonstrated using the Galleria mellonella invertebrate model [47].
Although all these plant products demonstrated antibacterial activity, their application in treatment of listeriosis requires further mammalian and clinical studies [44].

3. Prevention of Listeriosis

Currently, there is no effective vaccine against listeriosis, although some experiments have shown that cell-based and subunit-based immunoprepartions lacking cytotoxicity and pathogenicity may be highly protective [48][49][50]. Furthermore, L. monocytogenes is often applied as a vaccine vector for protection against other pathogens as well as in cancer therapy [51][52]. Therefore, prevention of L. monocytogenes infection is the most important way to control the disease, since the bacterium is widely distributed in the environment, including in food-production facilities [3][53]. It has been revealed that L. monocytogenes is able to survive there for a long time due to inadequate cleaning and disinfection of food production equipment or insufficient supervision of employees [17]. Most sporadic listeriosis cases and large outbreaks were due to the consumption of contaminated food with these bacteria, especially ready-to-eat food of animal origin [17]. Listeriosis is a typical zoonotic food-borne disease, although it may be also transmitted through direct contact with infected animals or contaminated environments [21][22].
There are studies on the prevention of L. monocytogenes infection by the use of probiotics [54][55][56][57][58]. Probiotic bacteria, e.g., lactobacilli, have shown positive effects in mice by producing bacteriocin or by changing the host gene expression or L. monocytogenes transcriptome [59]. Drolia et al. demonstrated that Lactobacillus casei expressing Listeria adhesion protein (LAP) colonized the intestine, adhered to the heat shock protein 60 (Hsp60) receptor, and excluded L. monocytogenes from intestinal colonization and systemic dissemination [57]. Furthermore, such probiotic bacteria were also able to prevent fetoplacental transmission of the pathogen in a pregnant guinea pig model [58]. Another study of Mathipa et al. showed that in L. casei expressing L. monocytogenes, InlA and InlB inhibited adhesion, invasion, and translocation of L. monocytogenes through enterocyte-like Caco-2 cells [56]. All these results suggest that molecularly recombinant probiotic bacteria possessing Listeria virulence traits may be a potential approach for prevention of human listeriosis.
The key aspect in prevention of listeriosis is proper food preparation, handling, and storage to avoid its contamination or cross-contamination and then consumption by humans [60][61][62]. According to the European Union food law regulation, the criteria for L. monocytogenes varies on the food category and intended consumer population [63]. Generally, there is zero tolerance for ready-to-eat foods for infants and for food of special medical purposes, and up to 100 cfu/g for other ready-to-eat foods.
Crucial factors for listeriosis prevention cover rapid and specific detection of L. monocytogenes in food with classical or alternative methods and determination of the infection sources [64]. L. monocytogenes is not only able to persist, but also multiply in a wide range of adverse conditions present in food production environments and create biofilms on various surfaces. All these features make it difficult to eliminate the bacteria and enable them to survive there for a long time [65]. Therefore, efficient methods of removal of the pathogen from the food industry environment, which are fundamental for ensuring the safety of food production, should be developed and applied [66].

References

  1. Murray, E.D.G.; Webb, R.A.; Swann, M.B.R. A disease of rabbits characterised by a large mononuclear leucocytosis, caused by a hitherto undescribed bacillus Bacterium monocytogenes (n.sp.). J. Pathol. Bacteriol. 1926, 29, 407–439.
  2. Nyfeldt, A. Etiologie de la mononucléose infectieuse. C. R. Sean. Soc. Biol. 1937, 101, 590–591.
  3. Dhama, K.; Karthik, K.; Tiwari, R.; Zubair Shabbir, M.; Barbuddhe, S.; Singh Malik, S.V.; Kumar Singh, R. Listeriosis in animals, its public health significance (food-borne zoonosis) and advances in diagnosis and control: A comprehensive review. Vet. Q. 2015, 35, 211–235.
  4. EFSA and ECDC (European Food Safety Authority and European Centre for Disease Prevention and Control). The European Union One Health 2019 zoonoses report. EFSA J. 2021, 19, e06406.
  5. Orsi, R.H.; Wiedmann, M. Characteristics and distribution of Listeria spp., including Listeria species newly described since 2009. Appl. Microbiol. Biotechnol. 2016, 100, 5273–5287.
  6. Carlin, R.C.; Liao, J.; Weller, D.; Guo, X.; Orsi, R.; Wiedmann, M. Listeria cossartiae sp. nov., Listeria immobilis sp. nov., Listeria portnoyi sp. nov. and Listeria rustica sp. nov., isolated from agricultural water and natural environments. Int. J. Syst. Evol. Microbiol. 2021, 71, 004795.
  7. Bagatella, S.; Tavares-Gomes, L.; Oevermann, A. Listeria monocytogenes at the interface between ruminants and humans: A comparative pathology and pathogenesis review. Vet. Pathol. 2022, 59, 186–210.
  8. Cummins, A.J.; Fielding, A.K.; McLaughlin, J. Listeria ivanovii infection in a patient with AIDS. J. Infect. 1994, 28, 89–91.
  9. De Bakker, H.C.; Cummings, C.A.; Ferreira, V.; Vatta, P.; Orsi, R.H.; Degoricija, L.; Baker, M.; Petrauskene, O.; Furtado, M.R.; Wiedmann, M. Comparative genomics of the bacterial genus Listeria: Genome evolution is characterized by limited gene acquisition and limited gene loss. BMC Genom. 2010, 11, 688.
  10. Rocourt, J.; Hof, H.; Schrettenbrunner, A.; Malinverni, R.; Bille, J. Acute purulent Listeria seelingeri meningitis in an immunocompetent adult. Schw. Mediz. Wochensch. 1986, 116, 248–251.
  11. Perrin, M.; Bremer, M.; Delamare, C. Fatal case of Listeria innocua bacteremia. J. Clin. Microbiol. 2003, 41, 5308–5309.
  12. Roberts, A.J.; Wiedmann, M. Pathogen, host and environmental factors contributing to the pathogenesis of listeriosis. Cell. Mol. Life Sci. 2003, 60, 904–918.
  13. Buchanan, R.L.; Stahl, H.G.; Whiting, R.C. Effects and interactions of temperature, pH, atmosphere, sodium chloride, and sodium nitrite on the growth of Listeria monocytogenes. J. Food Prot. 1989, 52, 844–851.
  14. Bucur, F.I.; Grigore-Gurgu, L.; Crauwels, P.; Riedel, C.U.; Nicolau, A.I. Resistance of Listeria monocytogenes to stress conditions encountered in food and food processing environments. Front. Microbiol. 2018, 9, 2700.
  15. Gray, M.J.; Freitag, N.E.; Boor, K.J. How the bacterial pathogen Listeria monocytogenes mediates the switch from environmental Dr. Jekyll to pathogenic Mr. Hyde. Infect. Immun. 2006, 74, 2505–2512.
  16. Ranasinghe, R.A.S.S.; Satharasinghe, D.A.; Tang, J.Y.H.; Rukayadi, Y.; Radu, K.R.; New, C.Y.; Son, R.; Premarathne, J.M.K.J.K. Persistence of Listeria monocytogenes in food commodities: Foodborne pathogenesis, virulence factors, and implications for public health. Food Res. 2021, 5, 1–16.
  17. Buchanan, R.L.; Gorris, L.G.M.; Hayman, M.M.; Jackson, T.C.; Whiting, R.C. A review of Listeria monocytogenes: An update on outbreaks, virulence, dose-response, ecology, and risk assessments. Food Control 2017, 75, 1–13.
  18. Ragon, M.; Wirth, T.; Hollandt, F.; Lavenir, R.; Lecuit, M.; Le Monnier, A.; Brisse, S. A new perspective on Listeria monocytogenes evolution. PLoS Path. 2008, 4, e1000146.
  19. Klumpp, J.; Loessner, M.J. Genomes, evolution, and application Listeria phages. Bacteriophage 2013, 3, e26861.
  20. Allerberger, F.; Wagner, M. Listeriosis: A resurgent foodborne infection. Clin. Microbiol. Infect. 2010, 16, 16–23.
  21. Vázquez-Boland, J.; Kuhn, M.; Berche, P.; Chakraborty, T.; Domiguez-Bernal, G.; Goebel, W.; González-Zorn, B.; Wehland, J.; Kreft, J. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 2001, 14, 584–640.
  22. Hilliard, A.; Leong, D.; O’Callaghan, A.; Culligan, E.P.; Morgan, C.A.; DeLappe, N.; Hill, C.; Jordan, K.; Cormican, M.; Gahan, C.G.N. Genomic characterization of Listeria monocytogenes isolates associated with clinical listeriosis and the food production environment in Ireland. Genes 2018, 9, 171.
  23. Charpentier, E.; Gerbaud, G.; Jacquet, C.; Rocourt, J.; Courvalin, P. Incidence of antibiotic resistance in Listeria species. J. Infect. Dis. 1995, 172, 277–281.
  24. Wieczorek, K.; Osek, J. Prevalence, genetic diversity and antimicrobial resistance of Listeria monocytogenes isolated from fresh and smoked fish in Poland. Food Microbiol. 2017, 64, 164–171.
  25. Gómez, D.; Azón, E.; Marco, N.; Carramiñana, J.J.; Rota, C.; Ariño, A.; Yangüela, J. Antimicrobial resistance of Listeria monocytogenes and Listeria innocua from meat products and meat-processing environment. Food Microbiol. 2014, 42, 61–65.
  26. Mpudu, P.; Mbewe, A.R.; Muma, J.B.; Mwasinga, W.; Mukumbuta, N.; Munyeme, M. A global perspective of antibiotic-resistant Listeria monocytogenes prevalence in assorted ready to eat foods: A systematic review. Vet. World 2021, 14, 2219–2229.
  27. Poyart-Salmeron, C.; Carlier, C.; Trieu-Cuot, P.; Courvalin, P.; Courtieu, A.L. Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes. Lancet 1990, 335, 1422–1426.
  28. Swaminathan, B.; Gerner-Smidt, P. The epidemiology of human listeriosis. Microb. Infect. 2007, 9, 1236–1243.
  29. Haubert, L.; Mendonça, M.; Lopes, G.V.; de Itapema Cardoso, M.R.; da Silva, W.P. Listeria monocytogenes isolates from food and food environment harbouring tetM and ermB resistance genes. Lett. Appl. Microbiol. 2015, 62, 23–29.
  30. Noll, M.; Kleta, S.; Al Dahouk, S. Antibiotic susceptibility of 259 Listeria monocytogenes strains isolated from food, food-processing plants and human samples in Germany. J. Infect. Public Health 2018, 11, 572–577.
  31. Rostamian, M.; Kooti, S.; Mohammadi, B.; Salimi, Y.; Akya, A. A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: The antibiotic susceptibility aspect. Diagn. Microbiol. Infect. Dis. 2022, 102, 115634.
  32. Temple, M.E.; Nahata, M.C. Treatment of listeriosis. Ann. Pharmacoth. 2000, 34, 656–661.
  33. Lamont, R.F.; Sobel, J.; Mazaki-Tovi, S.; Kusanovic, J.P.; Vaisbuch, E.; Kim, S.K.; Uldbjerg, N.; Romero, R. Listeriosis in human pregnancy: A systematic review. J. Perinat. Med. 2011, 39, 227–236.
  34. Janakiraman, V. Listeriosis in pregnancy: Diagnosis, treatment, and prevention. Rev. Obstet. Gynecol. 2008, 1, 179–185.
  35. Hernández-Díaz, S.; Werler, M.M.; Walker, A.M.; Mitchell, A.A. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am. J. Epidemiol. 2001, 153, 961–968.
  36. Lin, K.J.; Mitchell, A.A.; Yau, W.P.; Louik, C.; Hernández-Díaz, S. Safety of macrolides during pregnancy. Am. J. Obstet. Gynecol. 2013, 208, 221.e1–221.e8.
  37. Jakobsen, R.R.; Trinh, J.T.; Bomholtz, L.; Brok-Lauridsen, S.K.; Sulakvelidze, A.; Nielsen, D.S. A bacteriophage cocktail significantly reduces Listeria monocytogenes without deleterious impact on the commensal gut microbiota under simulated gastrointestinal conditions. Viruses 2022, 14, 190.
  38. Kawacka, I.; Olejnik-Schmidt, A.; Schmidt, M.; Sip, A. Natural plant-derived chemical compounds as Listeria monocytogenes inhibitors in vitro and in food model systems. Pathogens 2021, 10, 12.
  39. Banerji, R.; Karkee, A.; Saroj, S.D. Bacteriocins against foodborne pathogens (review). Appl. Biochem. Microbiol. 2022, 58, 518–539.
  40. Hammami, R.; Fernandez, B.; Lacroix, C.; Fliss, I. Anti-infective properties of bacteriocins: An update. Cell. Mol. Life Sci. 2013, 70, 2947–2967.
  41. O’Connor, P.M.; Ross, R.P.; Hill, C.; Cotter, P.D. Antimicrobial antagonists against food pathogens: A bacteriocin perspective. Curr. Opin. Food Sci. 2015, 2, 51–57.
  42. Fernandez, B.; Hammami, R.; Savard, P.; Jean, J.; Fliss, I. Pediococcus acidilactici UL5 and Lactococcus lactis ATCC 11454 are able to survive and express their bacteriocin genes under simulated gastrointestinal conditions. J. Appl. Microbiol. 2014, 116, 677–688.
  43. Fernandez, B.; Savard, P.; Fliss, I. Survival and metabolic activity of pediocin producer Pediococcus acidilactici UL5: Its impact on intestinal microbiota and Listeria monocytogenes in a model of the human terminal ileum. Microb. Ecol. 2016, 72, 931–942.
  44. Bouyahya, A.; Chamkhi, I.; Balahbib, A.; Rebezov, M.; Shariati, M.A.; Wilairatana, P.; Mubarak, M.S.; Benali, T.; El Omari, N. Mechanisms, anti-quorum-sensing actions, and clinical trials of medicinal plant bioactive compounds against bacteria: A comprehensive review. Molecules 2022, 27, 1484.
  45. Churklam, W.; Chaturongakul, S.; Ngamwongsatit, B.; Aunpad, R. The mechanisms of action of carvacrol and its synergism with nisin against Listeria monocytogenes on sliced bologna sausage. Food Control 2020, 108, 106864.
  46. Han, Y.; Sun, Z.; Chen, W. Antimicrobial susceptibility and antibacterial mechanism of limonene against Listeria monocytogenes. Molecules 2020, 25, 33.
  47. Upadhyay, A.; Venkitanarayanan, K. In vivo efficacy of trans-cinnamaldehyde, carvacrol, and thymol in attenuating Listeria monocytogenes infection in a Galleria mellonella model. J. Nat. Med. 2016, 70, 667–672.
  48. Calderón González, R.; Frande-Cabanes, E.; Bronchalo-Vicente, L.; Lecea-Cuello, M.J.; Pareja, E.; Bosch-Martínez, A.; Fanarraga, M.L.; Yañez-Díaz, S.; Carrasco-Marín, E.; Alvarez-Dominguez, C. Cellular vaccines in listeriosis: Role of the Listeria antigen GAPDH. Front. Cell. Infect. Microbiol. 2014, 4, 22.
  49. Phelps, C.C.; Vadia, S.; Boyaka, P.N.; Varikuti, S.; Attia, Z.; Dubey, P.; Satoskar, A.R.; Tweten, R.; Seveau, S. A listeriolysin O subunit vaccine is protective against Listeria monocytogenes. Vaccine 2020, 38, 5803–5813.
  50. Rahman, S.; Kumar Das, A. A subtractive proteomics and immunoinformatics approach towards designing a potential multi-epitope vaccine against pathogenic Listeria monocytogenes. Microbial Pathog. 2022, 172, 105782.
  51. Liu, D. Listeria-based anti-infective vaccine strategies. Recent Pat. Anti-Infect. Drug Discov. 2006, 1, 281–290.
  52. Flickinger, J., Jr.; Rodeck, U.; Snook, A. Listeria monocytogenes as a vector for cancer immunotherapy: Current understanding and progress. Vaccines 2018, 6, 48.
  53. Carpentier, B.; Cerf, O. Review—Persistence of Listeria monocytogenes in food industry equipment and premises. Int. J. Food Microbiol. 2011, 145, 1–8.
  54. Corr, S.C.; Gahan, C.G.M.; Hill, C. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol. Med. Microbiol. 2007, 50, 380–388.
  55. Koo, O.K.; Roshni Amalaradjou, M.A.; Bhunia, A.K. Recombinant probiotic expressing Listeria Adhesion Protein attenuates Listeria monocytogenes virulence in vitro. PLoS ONE 2012, 7, e29277.
  56. Mathipa, M.G.; Thantsha, M.S.; Bhunia, A.K. Lactobacillus casei expressing Internalins A and B reduces Listeria monocytogenes interaction with Caco-2 cells in vitro. Microb. Biotechnol. 2019, 12, 715–729.
  57. Drolia, R.; Roshni Amalaradjou, M.A.; Ryan, V.; Tenguria, S.; Liu, D.; Bai, X.; Xu, L.; Singh, A.K.; Cox, A.D.; Bernal-Crespo, V.; et al. Receptor-targeted engineered probiotics mitigate lethal Listeria infection. Nat. Commun. 2020, 11, 6344.
  58. Ryan, V.E.; Bailey, T.W.; Liu, D.; Vemulapalli, T.; Cooper, B.; Cox, A.D.; Bhunia, A.K. Listeria adhesion protein-expressing bioengineered probiotics prevent fetoplacental transmission of Listeria monocytogenes in a pregnant Guinea pig model. Microb. Pathog. 2021, 151, 104752.
  59. Archambaud, C.; Nahori, M.A.; Soubigou, G.; Cossart, P. Impact of lactobacilli on orally acquired listeriosis. Proc. Natl. Acad. Sci. USA 2012, 109, 16684–16689.
  60. Ferreira, V.; Wiedmann, M.; Teixeira, P.; Stasiewicz, M.J. Listeria monocytogenes persistence in food-associated environments: Epidemiology, strain characteristics, and implications for public health. J. Food Prot. 2014, 77, 150–170.
  61. Malley, T.J.V.; Butts, J.; Wiedmann, M. Seek and destroy process: Listeria monocytogenes process controls in the ready-to-eat meat and poultry industry. J. Food Prot. 2015, 78, 436–445.
  62. Sampedro, F.; Pérez-Rodríguez, F.; Servadio, J.L.; Gummalla, S.; Hedberg, C.W. Quantitative risk assessment model to investigate the public health impact of varying Listeria monocytogenes allowable levels in different food commodities: A retrospective analysis. Int. J. Food Microbiol. 2022, 383, 109932.
  63. Anon. Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs. Off. J. Eur. Union 2005, L 338/1. Available online: https://data.europa.eu/eli/reg/2005/2073/oj (accessed on 5 October 2022).
  64. Osek, J.; Lachtara, B.; Wieczorek, K. Listeria monocytogenes in foods—From culture identification to whole-genome characteristics. Food Sci. Nutr. 2022, 10, 2825–2854.
  65. Rodríguez-López, P.; Rodríguez-Herrera, J.J.; Vázquez-Sánchez, D.; López Cabo, M. Current knowledge on Listeria monocytogenes biofilms in food-related environments: Incidence, resistance to biocides, ecology and biocontrol. Foods 2018, 7, 85.
  66. Osek, J.; Lachtara, B.; Wieczorek, K. Listeria monocytogenes—How this pathogen survives in food-production environments? Front. Microbiol. 2022, 13, 866462.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Food Science & Technology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Jacek Osek
,
Kinga Wieczorek
View Times: 290
Revisions: 2 times (View History)
Update Date: 23 Dec 2022
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback